Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sirtuins | 5 | 2021 | 320 | 0.480 |
Why?
|
Neuroblastoma | 5 | 2022 | 1250 | 0.380 |
Why?
|
Gene Expression Regulation, Neoplastic | 18 | 2023 | 8552 | 0.310 |
Why?
|
Gene Expression Profiling | 23 | 2017 | 9420 | 0.310 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2021 | 641 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2017 | 2456 | 0.240 |
Why?
|
Cell Line, Tumor | 24 | 2023 | 16986 | 0.220 |
Why?
|
Zebrafish Proteins | 2 | 2020 | 1014 | 0.220 |
Why?
|
Histone Deacetylase Inhibitors | 5 | 2013 | 774 | 0.220 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2023 | 1609 | 0.200 |
Why?
|
Neurofibromin 1 | 2 | 2020 | 190 | 0.200 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2020 | 2917 | 0.190 |
Why?
|
Cell Differentiation | 13 | 2019 | 11530 | 0.190 |
Why?
|
Gangliosides | 1 | 2022 | 132 | 0.190 |
Why?
|
Glutamine | 1 | 2023 | 577 | 0.180 |
Why?
|
Neurofibrosarcoma | 1 | 2020 | 27 | 0.180 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2019 | 3615 | 0.170 |
Why?
|
Ants | 2 | 2010 | 32 | 0.170 |
Why?
|
RNA-Binding Proteins | 2 | 2020 | 1897 | 0.160 |
Why?
|
Sarcoma, Experimental | 1 | 2019 | 117 | 0.160 |
Why?
|
Genes, ras | 2 | 2018 | 654 | 0.160 |
Why?
|
Receptor, Notch1 | 2 | 2013 | 496 | 0.160 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2023 | 2827 | 0.150 |
Why?
|
GTPase-Activating Proteins | 1 | 2021 | 471 | 0.150 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2019 | 651 | 0.150 |
Why?
|
Haploinsufficiency | 1 | 2020 | 337 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 7 | 2020 | 5672 | 0.150 |
Why?
|
HSP90 Heat-Shock Proteins | 3 | 2010 | 424 | 0.140 |
Why?
|
ras Proteins | 2 | 2020 | 1054 | 0.140 |
Why?
|
Transcription Factors | 7 | 2020 | 12129 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2021 | 5305 | 0.140 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 226 | 0.140 |
Why?
|
Glycolysis | 1 | 2021 | 835 | 0.140 |
Why?
|
Proto-Oncogene Proteins | 3 | 2019 | 4513 | 0.130 |
Why?
|
Cell Survival | 8 | 2015 | 5791 | 0.130 |
Why?
|
Gene Expression | 7 | 2018 | 7581 | 0.130 |
Why?
|
Cell Proliferation | 11 | 2023 | 10448 | 0.130 |
Why?
|
Oligonucleotide Array Sequence Analysis | 10 | 2015 | 3778 | 0.130 |
Why?
|
Histone Deacetylase 2 | 2 | 2013 | 72 | 0.130 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2018 | 305 | 0.130 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2014 | 2057 | 0.130 |
Why?
|
Acetylation | 5 | 2019 | 1055 | 0.130 |
Why?
|
Histone Deacetylase 1 | 2 | 2013 | 133 | 0.120 |
Why?
|
RNA Polymerase II | 1 | 2019 | 539 | 0.120 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2016 | 132 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2020 | 805 | 0.120 |
Why?
|
Head and Neck Neoplasms | 2 | 2021 | 2895 | 0.120 |
Why?
|
Mice, SCID | 6 | 2020 | 2626 | 0.120 |
Why?
|
Zebrafish | 3 | 2020 | 3007 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2017 | 586 | 0.120 |
Why?
|
Neoplasms | 7 | 2023 | 22173 | 0.110 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2014 | 126 | 0.110 |
Why?
|
Cytosine | 1 | 2015 | 211 | 0.110 |
Why?
|
Gene Silencing | 1 | 2020 | 1509 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2021 | 3603 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2016 | 2872 | 0.110 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1349 | 0.110 |
Why?
|
Lactams | 1 | 2013 | 156 | 0.100 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2013 | 128 | 0.100 |
Why?
|
Transcriptional Activation | 1 | 2018 | 1756 | 0.100 |
Why?
|
Mutant Proteins | 1 | 2014 | 491 | 0.100 |
Why?
|
Mice | 22 | 2021 | 81533 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2008 | 1334 | 0.100 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2013 | 2425 | 0.100 |
Why?
|
RNA Interference | 7 | 2017 | 2832 | 0.100 |
Why?
|
Animals | 30 | 2021 | 168467 | 0.100 |
Why?
|
Receptors, Androgen | 3 | 2006 | 1079 | 0.100 |
Why?
|
Signal Transduction | 11 | 2020 | 23447 | 0.100 |
Why?
|
DNA-Binding Proteins | 3 | 2016 | 9610 | 0.100 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2016 | 727 | 0.100 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1902 | 0.100 |
Why?
|
Retinoblastoma Protein | 1 | 2015 | 672 | 0.090 |
Why?
|
Antineoplastic Agents | 5 | 2020 | 13642 | 0.090 |
Why?
|
Adenocarcinoma | 4 | 2020 | 6346 | 0.090 |
Why?
|
Animals, Genetically Modified | 3 | 2020 | 1561 | 0.090 |
Why?
|
Trans-Activators | 1 | 2020 | 2856 | 0.090 |
Why?
|
Pancreatic Neoplasms | 3 | 2020 | 5369 | 0.090 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2015 | 423 | 0.090 |
Why?
|
Benzodioxoles | 1 | 2010 | 75 | 0.090 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2012 | 411 | 0.090 |
Why?
|
Light | 1 | 2016 | 1353 | 0.090 |
Why?
|
Lysosomes | 1 | 2015 | 924 | 0.080 |
Why?
|
Leukemia | 2 | 2020 | 1522 | 0.080 |
Why?
|
Purines | 2 | 2010 | 607 | 0.080 |
Why?
|
Actins | 1 | 2016 | 2050 | 0.080 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2013 | 718 | 0.080 |
Why?
|
Cell Lineage | 2 | 2015 | 2556 | 0.080 |
Why?
|
Antibodies | 1 | 2017 | 2418 | 0.080 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2009 | 135 | 0.080 |
Why?
|
Cholangiocarcinoma | 1 | 2014 | 552 | 0.080 |
Why?
|
Bile Duct Neoplasms | 1 | 2014 | 605 | 0.080 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1745 | 0.080 |
Why?
|
Melanoma | 3 | 2017 | 5709 | 0.080 |
Why?
|
Mutation | 9 | 2020 | 30054 | 0.080 |
Why?
|
Retinoids | 1 | 2008 | 99 | 0.070 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2014 | 938 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5790 | 0.070 |
Why?
|
Histones | 5 | 2019 | 2580 | 0.070 |
Why?
|
Chromatin | 1 | 2019 | 2961 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2016 | 11904 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2015 | 1263 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2016 | 2448 | 0.070 |
Why?
|
HL-60 Cells | 4 | 2012 | 363 | 0.070 |
Why?
|
Genes, Insect | 1 | 2008 | 264 | 0.070 |
Why?
|
Quinazolines | 3 | 2015 | 1371 | 0.070 |
Why?
|
Autophagy | 1 | 2015 | 1326 | 0.070 |
Why?
|
Hepatocytes | 1 | 2014 | 1233 | 0.070 |
Why?
|
Janus Kinase 2 | 1 | 2010 | 560 | 0.070 |
Why?
|
Insect Proteins | 1 | 2008 | 254 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1626 | 0.070 |
Why?
|
RNA, Messenger | 7 | 2014 | 12794 | 0.070 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2009 | 359 | 0.070 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 2 | 2023 | 104 | 0.070 |
Why?
|
Galectin 3 | 1 | 2008 | 240 | 0.070 |
Why?
|
Genomics | 4 | 2012 | 5821 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2898 | 0.070 |
Why?
|
Humans | 51 | 2023 | 761572 | 0.070 |
Why?
|
Breast Neoplasms | 3 | 2020 | 21017 | 0.060 |
Why?
|
Dihydrotestosterone | 1 | 2006 | 195 | 0.060 |
Why?
|
RNA-Binding Protein EWS | 2 | 2023 | 210 | 0.060 |
Why?
|
Cytarabine | 1 | 2007 | 698 | 0.060 |
Why?
|
Biological Evolution | 1 | 2010 | 1071 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 4575 | 0.060 |
Why?
|
CDC2-CDC28 Kinases | 1 | 2004 | 110 | 0.060 |
Why?
|
Neoplasm Transplantation | 3 | 2015 | 2016 | 0.060 |
Why?
|
Myeloproliferative Disorders | 1 | 2010 | 613 | 0.060 |
Why?
|
Cyclins | 1 | 2006 | 594 | 0.060 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2015 | 1728 | 0.060 |
Why?
|
Prostatic Neoplasms | 5 | 2007 | 11122 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3639 | 0.050 |
Why?
|
Pheochromocytoma | 1 | 2005 | 328 | 0.050 |
Why?
|
Retina | 1 | 2014 | 2659 | 0.050 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2007 | 646 | 0.050 |
Why?
|
Disease Models, Animal | 6 | 2020 | 18253 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2019 | 988 | 0.050 |
Why?
|
Mice, Inbred NOD | 3 | 2014 | 1827 | 0.050 |
Why?
|
RNA, Small Interfering | 4 | 2017 | 3430 | 0.050 |
Why?
|
Glutamates | 1 | 2023 | 389 | 0.050 |
Why?
|
Transcription, Genetic | 5 | 2015 | 7593 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9280 | 0.050 |
Why?
|
Proline | 1 | 2023 | 457 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2016 | 7858 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2023 | 315 | 0.050 |
Why?
|
Disease Progression | 4 | 2021 | 13510 | 0.050 |
Why?
|
Social Behavior | 1 | 2008 | 1135 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2014 | 11742 | 0.050 |
Why?
|
Apoptosis | 5 | 2019 | 9489 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2008 | 1359 | 0.050 |
Why?
|
Erythropoiesis | 2 | 2019 | 683 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2021 | 14416 | 0.050 |
Why?
|
Neoplasm Metastasis | 3 | 2014 | 4915 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4026 | 0.050 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2016 | 634 | 0.050 |
Why?
|
Leukemia, Myeloid | 1 | 2004 | 694 | 0.050 |
Why?
|
Pharmaceutical Preparations | 1 | 2009 | 1089 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 17904 | 0.040 |
Why?
|
U937 Cells | 2 | 2012 | 261 | 0.040 |
Why?
|
Pentose Phosphate Pathway | 1 | 2021 | 126 | 0.040 |
Why?
|
Gene Knockdown Techniques | 2 | 2017 | 1612 | 0.040 |
Why?
|
Mice, Nude | 2 | 2017 | 3614 | 0.040 |
Why?
|
Proteomics | 2 | 2015 | 3848 | 0.040 |
Why?
|
Cell Line | 5 | 2019 | 15601 | 0.040 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2005 | 732 | 0.040 |
Why?
|
Transfection | 3 | 2015 | 5774 | 0.040 |
Why?
|
Epigenesis, Genetic | 3 | 2020 | 3801 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2022 | 9177 | 0.040 |
Why?
|
Protein Kinases | 1 | 2006 | 1608 | 0.040 |
Why?
|
bcl-X Protein | 2 | 2015 | 410 | 0.040 |
Why?
|
Single-Cell Analysis | 2 | 2021 | 2450 | 0.040 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2020 | 255 | 0.040 |
Why?
|
Flow Cytometry | 4 | 2013 | 5869 | 0.040 |
Why?
|
Genome, Human | 3 | 2006 | 4425 | 0.040 |
Why?
|
Microphthalmia-Associated Transcription Factor | 2 | 2015 | 259 | 0.040 |
Why?
|
Androgens | 1 | 2006 | 1286 | 0.040 |
Why?
|
Glutathione | 1 | 2021 | 583 | 0.040 |
Why?
|
Heterozygote | 2 | 2020 | 2787 | 0.040 |
Why?
|
Transcriptional Elongation Factors | 1 | 2019 | 165 | 0.040 |
Why?
|
Globins | 1 | 2019 | 404 | 0.040 |
Why?
|
RNA, Neoplasm | 1 | 2021 | 750 | 0.040 |
Why?
|
Genotype | 4 | 2015 | 12990 | 0.040 |
Why?
|
Molecular Structure | 2 | 2016 | 1880 | 0.040 |
Why?
|
Tumor Cells, Cultured | 3 | 2013 | 6132 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 2 | 2009 | 465 | 0.040 |
Why?
|
Phosphorylation | 3 | 2014 | 8321 | 0.040 |
Why?
|
Anoikis | 1 | 2017 | 48 | 0.040 |
Why?
|
Carboxy-Lyases | 1 | 2017 | 85 | 0.030 |
Why?
|
Peptide Synthases | 1 | 2017 | 80 | 0.030 |
Why?
|
Limonins | 2 | 2006 | 24 | 0.030 |
Why?
|
E2F1 Transcription Factor | 1 | 2017 | 178 | 0.030 |
Why?
|
Gene Amplification | 2 | 2014 | 1089 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2017 | 404 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5315 | 0.030 |
Why?
|
Aneuploidy | 1 | 2020 | 552 | 0.030 |
Why?
|
Retroviridae | 1 | 2018 | 850 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 802 | 0.030 |
Why?
|
Estrogens | 2 | 2017 | 1522 | 0.030 |
Why?
|
Azo Compounds | 1 | 2016 | 117 | 0.030 |
Why?
|
Female | 15 | 2021 | 392686 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2008 | 4369 | 0.030 |
Why?
|
Small Molecule Libraries | 2 | 2013 | 733 | 0.030 |
Why?
|
Extracellular Space | 1 | 2017 | 563 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2017 | 6214 | 0.030 |
Why?
|
Testosterone | 1 | 2006 | 2472 | 0.030 |
Why?
|
Lymphoma, B-Cell | 1 | 2002 | 940 | 0.030 |
Why?
|
Ribosomal Protein S6 | 1 | 2014 | 71 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2007 | 2529 | 0.030 |
Why?
|
Enzyme Inhibitors | 3 | 2013 | 3713 | 0.030 |
Why?
|
5-Methylcytosine | 1 | 2015 | 148 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2019 | 1125 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2015 | 371 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2811 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2015 | 223 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 2017 | 702 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2015 | 1406 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9541 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2014 | 186 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2231 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2015 | 436 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2014 | 126 | 0.030 |
Why?
|
Cell Division | 2 | 2014 | 4465 | 0.030 |
Why?
|
Receptors, Glutamate | 1 | 2014 | 228 | 0.030 |
Why?
|
SOXB1 Transcription Factors | 1 | 2015 | 286 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22172 | 0.030 |
Why?
|
Thapsigargin | 1 | 2013 | 102 | 0.030 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2014 | 296 | 0.030 |
Why?
|
Antioxidants | 1 | 2021 | 1668 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 318 | 0.030 |
Why?
|
Dioxygenases | 1 | 2015 | 345 | 0.030 |
Why?
|
Glutarates | 1 | 2014 | 243 | 0.030 |
Why?
|
Fatty Acids | 1 | 2020 | 1808 | 0.020 |
Why?
|
Teratoma | 1 | 2015 | 404 | 0.020 |
Why?
|
Blotting, Western | 2 | 2013 | 5035 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2002 | 1405 | 0.020 |
Why?
|
Gene Deletion | 1 | 2019 | 2665 | 0.020 |
Why?
|
Technology, Pharmaceutical | 1 | 2012 | 84 | 0.020 |
Why?
|
Soft Tissue Neoplasms | 1 | 2020 | 1159 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1858 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2002 | 4352 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 2020 | 0.020 |
Why?
|
Databases, Factual | 1 | 2006 | 7967 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4280 | 0.020 |
Why?
|
Prognosis | 4 | 2017 | 29629 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2013 | 2865 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 615 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2014 | 719 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13382 | 0.020 |
Why?
|
Pyridines | 2 | 2014 | 2875 | 0.020 |
Why?
|
Cell Cycle | 1 | 2018 | 2932 | 0.020 |
Why?
|
Tretinoin | 1 | 2013 | 519 | 0.020 |
Why?
|
Gene Library | 1 | 2013 | 1059 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2014 | 10766 | 0.020 |
Why?
|
DNA Damage | 1 | 2020 | 2449 | 0.020 |
Why?
|
Cell Culture Techniques | 2 | 2008 | 1667 | 0.020 |
Why?
|
Alleles | 2 | 2013 | 6864 | 0.020 |
Why?
|
Aniline Compounds | 1 | 2015 | 1069 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 1962 | 0.020 |
Why?
|
Thrombocythemia, Essential | 1 | 2010 | 113 | 0.020 |
Why?
|
Sarcoma | 1 | 2020 | 1801 | 0.020 |
Why?
|
Amino Acids | 1 | 2015 | 1718 | 0.020 |
Why?
|
Calcium Channels | 1 | 2013 | 620 | 0.020 |
Why?
|
Polycythemia Vera | 1 | 2010 | 161 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2018 | 3396 | 0.020 |
Why?
|
Survival Analysis | 2 | 2017 | 10090 | 0.020 |
Why?
|
Thrombopoiesis | 1 | 2010 | 165 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2002 | 3963 | 0.020 |
Why?
|
Neurogenesis | 1 | 2015 | 863 | 0.020 |
Why?
|
Male | 13 | 2019 | 360842 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2010 | 1141 | 0.020 |
Why?
|
Immunomagnetic Separation | 1 | 2008 | 79 | 0.020 |
Why?
|
Primary Myelofibrosis | 1 | 2010 | 209 | 0.020 |
Why?
|
Receptors, CCR7 | 1 | 2008 | 107 | 0.020 |
Why?
|
3T3 Cells | 1 | 2010 | 1085 | 0.020 |
Why?
|
Cell Movement | 1 | 2020 | 5205 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2013 | 1246 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1120 | 0.020 |
Why?
|
Africa | 1 | 2010 | 709 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9353 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2019 | 3449 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2010 | 1060 | 0.020 |
Why?
|
Reproducibility of Results | 4 | 2008 | 20099 | 0.020 |
Why?
|
Oxazines | 1 | 2009 | 350 | 0.020 |
Why?
|
Fluorometry | 1 | 2007 | 99 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2002 | 2578 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2707 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 934 | 0.020 |
Why?
|
Metribolone | 1 | 2006 | 13 | 0.020 |
Why?
|
Pentacyclic Triterpenes | 1 | 2006 | 35 | 0.020 |
Why?
|
Phenothiazines | 1 | 2006 | 61 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2017 | 2644 | 0.020 |
Why?
|
Cyclin D | 1 | 2006 | 72 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4652 | 0.020 |
Why?
|
Hydroxysteroid Dehydrogenases | 1 | 2006 | 29 | 0.020 |
Why?
|
3-Hydroxysteroid Dehydrogenases | 1 | 2006 | 34 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2017 | 2557 | 0.020 |
Why?
|
Morpholines | 1 | 2009 | 581 | 0.020 |
Why?
|
Hydroxyprostaglandin Dehydrogenases | 1 | 2006 | 31 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1745 | 0.020 |
Why?
|
Triterpenes | 1 | 2006 | 76 | 0.020 |
Why?
|
Metabolomics | 1 | 2015 | 1659 | 0.020 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 382 | 0.020 |
Why?
|
DNA Methylation | 1 | 2020 | 4399 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2010 | 868 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2006 | 203 | 0.020 |
Why?
|
Benzoquinones | 1 | 2006 | 198 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 2803 | 0.020 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2008 | 330 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 1646 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5439 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2416 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2006 | 384 | 0.020 |
Why?
|
Aminopyridines | 1 | 2009 | 573 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2010 | 1699 | 0.020 |
Why?
|
Drosophila | 1 | 2013 | 1495 | 0.020 |
Why?
|
E-Box Elements | 1 | 2004 | 20 | 0.020 |
Why?
|
gp100 Melanoma Antigen | 1 | 2004 | 38 | 0.020 |
Why?
|
Sulfonamides | 1 | 2015 | 1978 | 0.020 |
Why?
|
Tyrosine | 1 | 2009 | 1440 | 0.020 |
Why?
|
Phenotype | 2 | 2015 | 16592 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2007 | 1762 | 0.020 |
Why?
|
Lactams, Macrocyclic | 1 | 2006 | 318 | 0.010 |
Why?
|
Molecular Weight | 1 | 2007 | 2186 | 0.010 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2005 | 313 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 2385 | 0.010 |
Why?
|
Histone Deacetylases | 1 | 2009 | 720 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2004 | 184 | 0.010 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2006 | 431 | 0.010 |
Why?
|
Child | 2 | 2023 | 80156 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2006 | 1302 | 0.010 |
Why?
|
MicroRNAs | 1 | 2020 | 3816 | 0.010 |
Why?
|
Homeostasis | 1 | 2015 | 3323 | 0.010 |
Why?
|
Myeloid Cells | 1 | 2009 | 823 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2015 | 2882 | 0.010 |
Why?
|
Drug Synergism | 1 | 2008 | 1756 | 0.010 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2005 | 343 | 0.010 |
Why?
|
Pyrazoles | 1 | 2014 | 2009 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3877 | 0.010 |
Why?
|
Microspheres | 1 | 2007 | 784 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3612 | 0.010 |
Why?
|
S Phase | 1 | 2004 | 421 | 0.010 |
Why?
|
Homozygote | 1 | 2008 | 1776 | 0.010 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2015 | 1860 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2005 | 662 | 0.010 |
Why?
|
Species Specificity | 1 | 2007 | 2414 | 0.010 |
Why?
|
Translocation, Genetic | 1 | 2009 | 1393 | 0.010 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2006 | 410 | 0.010 |
Why?
|
Tandem Mass Spectrometry | 1 | 2009 | 1188 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 666 | 0.010 |
Why?
|
Ligands | 1 | 2010 | 3272 | 0.010 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2006 | 495 | 0.010 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2006 | 598 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2010 | 1878 | 0.010 |
Why?
|
Genetic Variation | 2 | 2008 | 6567 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2006 | 678 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1651 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2010 | 2693 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8466 | 0.010 |
Why?
|
Protein Array Analysis | 1 | 2004 | 400 | 0.010 |
Why?
|
Haplotypes | 1 | 2008 | 2713 | 0.010 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2004 | 855 | 0.010 |
Why?
|
Predictive Value of Tests | 3 | 2002 | 15266 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2006 | 1062 | 0.010 |
Why?
|
DNA Primers | 1 | 2006 | 2819 | 0.010 |
Why?
|
Stem Cells | 1 | 2014 | 3523 | 0.010 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2004 | 655 | 0.010 |
Why?
|
Treatment Outcome | 4 | 2015 | 64684 | 0.010 |
Why?
|
Melanocytes | 1 | 2004 | 509 | 0.010 |
Why?
|
Enzymes | 1 | 2002 | 257 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 6056 | 0.010 |
Why?
|
Genetic Techniques | 1 | 2004 | 428 | 0.010 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2002 | 393 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12463 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2004 | 1529 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11076 | 0.010 |
Why?
|
Time Factors | 2 | 2014 | 39970 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2006 | 3597 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5799 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2017 | 10194 | 0.010 |
Why?
|
Genome | 1 | 2007 | 1740 | 0.010 |
Why?
|
Sirolimus | 1 | 2006 | 1533 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18965 | 0.010 |
Why?
|
Vincristine | 1 | 2002 | 1036 | 0.010 |
Why?
|
Dexamethasone | 1 | 2006 | 1948 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 1903 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2002 | 1848 | 0.010 |
Why?
|
Proteins | 2 | 2004 | 6032 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15732 | 0.010 |
Why?
|
Middle Aged | 4 | 2020 | 220920 | 0.010 |
Why?
|
Organ Specificity | 1 | 2002 | 1968 | 0.010 |
Why?
|
Pedigree | 1 | 2005 | 4542 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2002 | 2218 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 1551 | 0.010 |
Why?
|
Pyrimidines | 1 | 2009 | 3028 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21355 | 0.010 |
Why?
|
Prednisone | 1 | 2002 | 1563 | 0.010 |
Why?
|
Lung | 1 | 2015 | 10002 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2002 | 2220 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2007 | 2226 | 0.010 |
Why?
|
Doxorubicin | 1 | 2002 | 2224 | 0.010 |
Why?
|
Base Sequence | 1 | 2006 | 12441 | 0.010 |
Why?
|
Fibroblasts | 1 | 2004 | 4141 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3701 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 7237 | 0.010 |
Why?
|
Adult | 3 | 2020 | 221203 | 0.010 |
Why?
|
Software | 1 | 2006 | 4434 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 9469 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2002 | 6815 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2002 | 3312 | 0.010 |
Why?
|
Infant | 1 | 2010 | 36192 | 0.000 |
Why?
|
Insulin | 1 | 2002 | 6597 | 0.000 |
Why?
|
Muscle, Skeletal | 1 | 2002 | 4948 | 0.000 |
Why?
|
Aged | 2 | 2015 | 169310 | 0.000 |
Why?
|
Liver | 1 | 2002 | 7529 | 0.000 |
Why?
|
Rats | 1 | 2002 | 23741 | 0.000 |
Why?
|
Alzheimer Disease | 1 | 2006 | 8601 | 0.000 |
Why?
|
Obesity | 1 | 2006 | 12947 | 0.000 |
Why?
|
Risk Factors | 1 | 2002 | 74213 | 0.000 |
Why?
|